This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 1531493

PUBLISHED DESCRIPTION

5510023/2014

Parties involved

Place of performance
Portugal, Coimbra, Coimbra
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
GILEAD SCIENCES, LDA · Tax ID 503604704
Awardee
Bristol Myers Squibb · Tax ID 500048193
Awardee
JANSSEN CILAG FARMACEUTICA, LDA · Tax ID 500189412
Awardee
VIIVVHIV HEALTHCARE, UNIPESSOAL LDA · Tax ID 509117961
Awardee
ABBVIE, LDA · Tax ID 510229050
Awardee
UNILFARMA, LDA · Tax ID 500293023
Awardee
ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Awardee
MERCK SHARP E DOHME, LDA · Tax ID 500191360

Values and timeline

Contract price
€11,663,507.38
Procedure base price
€0.00
Total effective price
€11,348,915.78
Publication date
27 August 2015
Award date
6 February 2014
Signing date
6 February 2014
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Not stated
CPV code
33698000-9 - Produtos para fins clínicos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 18/2008)
Framework agreement
ACORDO QUADRO PARA FORNECIMENTO DE DERIVADOS DO PLASMA HUMANO ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE CP 2015/9
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
1516152

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts